Share Email Print
Programs Undergraduate Programs Graduate Programs Postbaccalaureate & Certificate Programs Online Programs Transfer Programs University Catalog Schools Clinical Affiliations Postgraduate Opportunities Academic Support & Resources Center for Professional Career Development Continuing Education

Fellowships & Residencies

Genzyme Biopharmaceutical Fellowships

These two-year Post-PharmD Industry Fellowships are intended to provide a comprehensive experience for Doctor of Pharmacy graduates within the biopharmaceutical industry. Currently, seven programs across five specialties are offered:

  • Clinical Documentation (Medical Writing)
  • Clinical Supplies / Investigational Products
  • Global Pharmacovigilance and Epidemiology
  • Medical Affairs (Multiple Sclerosis, Rare Diseases, Oncology)
  • Regulatory Affairs

Please see the brochure for additional details and feel free to review the content below.


The fellowship will provide a competitive stipend and benefits package, including comprehensive health insurance. In addition, the fellowship will offer an allowance for travel to conferences in pharmacy and other specialty areas. The fellow may qualify for student loan deferment, allowing for the postponement of loan payments until the completion of the fellowship program. The lender of the student loan(s) will be able to provide specific information regarding eligibility and terms of deferment.

Certificate of Completion

MCPHS University and Genzyme, a Sanofi company will award a certificate of achievement upon successful completion of the fellowship program.

Clinical Supplies / Investigational Products

As an integral member of the Clinical Supplies (CS) department in Genzyme, the Clinical Pharmacy Fellow will have the opportunity to gain valuable experience in clinical study design and investigational products management as well as provide clinical pharmacy expertise to the multi-disciplinary project teams at Genzyme.

Global Pharmacovigilance and Epidemiology

The Global Pharmacovigilance and Epidemiology (GPE) Department at Genzyme, a Sanofi Company, is responsible for the monitoring, assessment, and communication of safety information throughout a product’s lifecycle. The Fellow will rotate through and support different therapeutic areas (e.g. Rare Diseases, Multiple Sclerosis, Oncology) within Safety Surveillance & Risk Management (SSRM) and contribute to projects involving multi-disciplinary teams (e.g. Clinical, Medical, Regulatory, Labeling). They will learn about pharmacovigilance tools and methodologies while at the same time enhance their leadership qualities and soft skills.

Medical Affairs – Rare Diseases

The fellow will gain a thorough understanding of rare genetic conditions and the role of Medical Affairs through a rotation-based experience and contributions to publications and medical education programs and materials. As an integral member of the Rare Diseases Medical Affairs Department in Genzyme, the Rare Diseases Medical Affairs Fellow will have the opportunity to gain valuable experience in the operations of Medical Affairs supporting publications and field medical in addition to interacting with Key Opinion Leaders.

Medical Affairs - Oncology

The Medical Affairs (Sanofi Oncology) Fellow will have the unique opportunity to gain medical affairs experience in a number of core functions through departmental rotations as well as the opportunity for an experiential clinical oncology site rotation. Departmental rotations include, but are not limited to Publications, Medical Education, Scientific Communication, Investigator Sponsored Trials, and Stakeholder Relations. Additionally, the fellow will have the opportunity to pursue other interests through a series of elective rotations, during which they will gain insight into the integral and strategic roles of various groups within the Transplant Oncology Business Unit throughout a product’s life cycle.

Regulatory Affairs

The Regulatory Affairs (RA) Fellow will gain experience across a number of specialties within the Regulatory Affairs department. This will include regulatory product development of drugs and medical devices, Chemistry, Manufacturing and Controls, Regulatory International, Advertising and Promotion, and Regulatory Intelligence. Upon completion of the two-year program, the fellow will develop an in-depth understanding of RA and the drug development process from pre-clinical to post-marketing.

New programs beginning the 2014-2016 fellowship years:

Medical Affairs – Multiple Sclerosis

The Medical Affairs Fellow in the Genzyme Multiple Sclerosis Business Unit will have the unique opportunity to gain medical affairs experience in a number of core functions through departmental rotations (both longitudinal and elective experiences). Core departmental rotations include, but are not limited to Field and Home Office Medical functions, Publications, Medical Communications, Pharmacovigilance, and Medical Information Services. The program will place a longitudinal emphasis on the field medical function (medical science liaison) where the fellow will gain both field, operational, and project management experience.

Clinical Documentation (Medical Writing)

The Clinical Documentation Department, in the Clinical Sciences & Operations platform of global Research & Development, includes medical writing activities to prepare regulated documentation for the Sanofi clinical development programs. In addition, the department is responsible for public disclosure of clinical trial information, quality control, and electronic document management, and is developing an innovative approach to structured content management.


The fellow will be selected on a nationally competitive basis. Applicants must have a Doctor of Pharmacy degree from an ACPE-accredited college of pharmacy. Candidates must have strong written and verbal communication skills and an interest in pursuing a career within the biopharmaceutical industry. Applicants must be a U.S. citizen or have permanent U.S. resident status.


Interested individuals should send:

  • A curriculum vitae
  • A letter of interest
  • Three letters of recommendation
  • An official college transcript

Completed applications are accepted from November 1st to January 1st. Early submission is highly encouraged due to the competitive nature of the fellow selection process. Electronic copies of the application materials may be provided; however, a hard copy of the official college transcript is required. In addition, electronic letters of recommendation each with a Recommendation Request Form must be sent directly from the reference’s work email.

All correspondence (excluding transcript) should be sent via e-mail to:
Brian Fulling, PharmD
Medical Science Liaison
Genetic Diseases
US Medical Affairs